SOPHiA GENETICS S.A. (SOPH) Company Future Sales Volume

SOPHiA GENETICS SA (SOPH) generates revenue through B2B subscriptions for AI-powered genome analysis software. A global network of clinics integrated via this "digital brain" renders the system indispensable. On GURU.Markets, the organization's projected sales are available as a trend, where the 0.09 metric indicates the status of its fundamental value. High customer retention rates and a lack of barriers ensure a steady influx of new hospitals into the ecosystem.

SOPH - SOPHiA GENETICS SA Company Sales Forecast over the range 07/04/2022 - 11/15/2026

SOPHiA GENETICS SA (SOPH) - metric breakdowns and financial figures

- stock quotes and analyst forecast:

Stock Price sophiagenetics.com|SOPH - Analyst Consensus Forecast

- market capitalization details:

Market Valuation SOPHiA GENETICS SA|SOPH - Value Adjusted for Debt and Cash

- issuer book value statistics:

Book Value per Share SOPHiA GENETICS SA|SOPH - Book Value of Business|Market Capitalization to Book Value Ratio sophiagenetics.com|SOPH - Company Assets

- debt burden and liquidity indicators:

- earnings and market ratios statistics:

SOPH - Net Income|Expected Profit SOPHiA GENETICS SA|SOPH - Business Payback Period|Projected Price to Earnings Sophia Genetics|SOPH - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization SOPHiA GENETICS|SOPH - Operating income before deduction of amortization|Net earnings per share (EPS TTM) SOPHiA GENETICS SA|SOPH - Net earnings per share (EPS TTM)|Year-over-year earnings per share growth for the last twelve months sophiagenetics.com|SOPH - Expected net earnings per share growth this year|Net earnings per share growth forecast for next year SOPHiA GENETICS SA

- revenue and sales details:

SOPH - Company Total Revenue|Company Projected Revenue sophiagenetics.com|SOPH - Price-to-Sales Ratio|Forward P/S Multiple SOPHiA GENETICS SA

Analysis of all company metrics:SOPHiA GENETICS SOPH

Signature product of SOPHiA GENETICS S.A.

Professional capital evaluates SOPHiA GENETICS SA (SOPH) through the lens of SaaS contract scalability and the transparency of bioinformatics metrics that validate the competencies of the Swiss management. By analyzing revenue expectations from the company's sales, the investor determines the operational resilience of the model: low volatility in the trend guarantees protection against drawdowns, whereas sharp fluctuations signal structural changes in demand that impact the ultimate reliability of the asset.

Key competitors